Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Camzyos
Camzyos
departments:
心内科
drug:
胶囊
Active:
mavacamten
indication:
用于治疗成人阻塞性肥厚型心肌病(oHCM)
Licensor:
Bristol-Myers Squibb Pharma EEIG
Approved Country/Region:
欧盟
Approval time:
2023-06-26